Φορτώνει......
Use of Ribavirin for Hepatitis C Treatment in the Modern Direct-acting Antiviral Era
Ribavirin, once a staple of hepatitis C treatment, has significant drawbacks, including treatment-limiting side effects, the requirement for intensive laboratory monitoring, the need for frequent dose adjustments, and teratogenicity. These factors make it difficult to escalate ribavirin-based HCV tr...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | J Clin Transl Hepatol |
|---|---|
| Κύριοι συγγραφείς: | , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
XIA & HE Publishing Inc.
2018
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6328726/ https://ncbi.nlm.nih.gov/pubmed/30637222 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14218/JCTH.2018.00007 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|